Eikon Therapeutics

Roger Perlmutter was the President of Merck Research Laboratories from April 2013 to December 2020. Roger is currently the CEO of Eikon Therapeutics.

Dan Anderson - Chief Scientific Officer, Ashish Kheterpal - Chief Information Officer, and Russ Berman - Chief Technical Officer report to Roger Perlmutter.

Merck

CEO and Executive Team

Leadership Team

Director, Regulatory Clinical Strategy

Associate Director, Supplier Relationship Management & Performance – Clinical Outsourced Services

Clinical Trial Associate, Oncology, Asia

Clinical Program Manager, Oncology, Asia

Clinical Trial Manager, Oncology, Asia

Senior Medical Writer

Clinical Trial Associate, Oncology, EMEA

Scientist 2, Cellular Assays

Clinical Trial Associate, Oncology

Clinical Trial Manager, Oncology

Associate Director, Biostatistics

Principal Engineer, Data Integration

Associate Director, Data Management

Scientist 1, Research Biology (neuroscience)

Vice President, Information Security

Executive Assistant To The Chief Scientific Officer

Staff Systems Engineer

Senior Engineer, Machine Learning - Chemistry

Electrical Engineering Technician

Director, Clinical Operations Study Management, EMEA & Asia

Scientist 2, Computational Chemistry

Eikon G&a Community

Eikon Engineering Community

Eikon Clinical Community

Vice President, Business Operations

Roger Perlmutter

CEO at Eikon Therapeutics

Org chart

Peers

Reports

Teams

CEO and Executive Team

Leadership Team

Timeline

CEO